Trial Outcomes & Findings for Effectiveness of the Rapid Intravascular Start (RIVS) System Versus Conventional Catheter (NCT NCT00914069)
NCT ID: NCT00914069
Last Updated: 2017-04-13
Results Overview
A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.
TERMINATED
NA
175 participants
An access attempt usually ranges from 0 to 45 minutes in duration.
2017-04-13
Participant Flow
Prior to assignment to groups, two subjects withdrew from the study. Also prior to group assignment, one subject did not have a consent form and was excluded from the study.
Participant milestones
| Measure |
RIVS Vascular Access
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
|---|---|---|
|
Overall Study
STARTED
|
84
|
88
|
|
Overall Study
COMPLETED
|
84
|
88
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Sex data were missing for two (2) subjects.
Baseline characteristics by cohort
| Measure |
RIVS Vascular Access
n=84 Participants
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
n=88 Participants
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
Total
n=172 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
66.1 years
STANDARD_DEVIATION 9.4 • n=84 Participants
|
67.2 years
STANDARD_DEVIATION 10.9 • n=88 Participants
|
66.7 years
STANDARD_DEVIATION 10.2 • n=172 Participants
|
|
Sex: Female, Male
Female
|
36 Participants
n=84 Participants • Sex data were missing for two (2) subjects.
|
49 Participants
n=86 Participants • Sex data were missing for two (2) subjects.
|
85 Participants
n=170 Participants • Sex data were missing for two (2) subjects.
|
|
Sex: Female, Male
Male
|
48 Participants
n=84 Participants • Sex data were missing for two (2) subjects.
|
37 Participants
n=86 Participants • Sex data were missing for two (2) subjects.
|
85 Participants
n=170 Participants • Sex data were missing for two (2) subjects.
|
|
Race/Ethnicity, Customized
White
|
42 participants
n=84 Participants
|
44 participants
n=88 Participants
|
86 participants
n=172 Participants
|
|
Race/Ethnicity, Customized
Black
|
10 participants
n=84 Participants
|
10 participants
n=88 Participants
|
20 participants
n=172 Participants
|
|
Race/Ethnicity, Customized
Asian
|
14 participants
n=84 Participants
|
16 participants
n=88 Participants
|
30 participants
n=172 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
10 participants
n=84 Participants
|
7 participants
n=88 Participants
|
17 participants
n=172 Participants
|
|
Race/Ethnicity, Customized
Other
|
8 participants
n=84 Participants
|
9 participants
n=88 Participants
|
17 participants
n=172 Participants
|
PRIMARY outcome
Timeframe: An access attempt usually ranges from 0 to 45 minutes in duration.A successful IV insertion includes all of the following: initial vein penetration, which is visualized by a flash back of blood into the access device, deployment of the guidewire, advancement of the catheter into the vein, retraction of needle and guidewire, and flushing of IV. A secured flushed IV will be indicative of a successful PIV placement.
Outcome measures
| Measure |
RIVS Vascular Access
n=84 Participants
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
n=88 Participants
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
|---|---|---|
|
IV Insertion Success Rate at First Attempt IV Insertion Success Rate at First Attempt
|
60 participants
|
51 participants
|
PRIMARY outcome
Timeframe: Post-PIV placement until catheter removal (usually within 4 days)Any device-related or procedure-related adverse event that causes clinically consequential symptoms to the patient. These may include access site hematoma, bleeding, infection, nerve injury, vessel laceration, wound dehiscence, allergic reaction, or inflammation, among others.
Outcome measures
| Measure |
RIVS Vascular Access
n=84 Participants
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
n=88 Participants
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
|---|---|---|
|
Summary of Major Complications
|
0 participants
|
0 participants
|
SECONDARY outcome
Timeframe: An access attempt usually ranges from 0 to 45 minutes in duration.A secured flushed IV will be indicative of a successful PIV placement.
Outcome measures
| Measure |
RIVS Vascular Access
n=84 Participants
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
n=88 Participants
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
|---|---|---|
|
Time Required to Obtain Access
|
4.0 minutes
Standard Deviation 4.0
|
5.0 minutes
Standard Deviation 5.0
|
SECONDARY outcome
Timeframe: An access attempt usually ranges from 0 to 45 minutes in duration.Population: Number of Participants Analyzed is not consistent with numbers provided in the Participant Flow Module because not all participants required a second attempt at catheter placement.
A secured flushed IV will be indicative of a successful PIV placement.
Outcome measures
| Measure |
RIVS Vascular Access
n=23 Participants
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
n=36 Participants
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
|---|---|---|
|
Second Stick Success Rate
|
10 participants
|
18 participants
|
SECONDARY outcome
Timeframe: Post-PIV placement until catheter removal (usually within 4 days)Any device-related or procedure-related adverse event that causes clinically inconsequential symptoms to the patient.
Outcome measures
| Measure |
RIVS Vascular Access
n=84 Participants
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
n=88 Participants
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
|---|---|---|
|
Summary of Minor Complications
|
1 participants
|
0 participants
|
Adverse Events
RIVS Vascular Access
Conventional Vascular Access
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
RIVS Vascular Access
n=84 participants at risk
RIVS vascular access
RIVS vascular access: Access to peripheral vasculature
|
Conventional Vascular Access
n=88 participants at risk
Conventional vascular access
Conventional vascular access: Vascular access using conventional venous access device
|
|---|---|---|
|
Vascular disorders
Minor Vasular Complication
|
1.2%
1/84
|
0.00%
0/88
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee The Principal Investigators may publish or present the study results with prior consent of the Sponsor, but will not disclose confidential information. Prior to submission by a Principal Investigator for publication or presentation, the Sponsor will be provided with the opportunity to review the submission for confidential information and accuracy.
- Publication restrictions are in place
Restriction type: OTHER